These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1746907)

  • 1. Determination of TNF alpha, interferon alpha, interleukin 2 and reactivity in the leucocyte migration inhibition test in breast cancer patients.
    Mallmann P; Diedrich K; Mallmann R; Koenig UD; Krebs D
    Anticancer Res; 1991; 11(4):1509-15. PubMed ID: 1746907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients.
    Mallmann P; Dietrich K; Krebs D
    Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):699-706. PubMed ID: 2151629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tamoxifen on parameters of cell-mediated immunity in postmenopausal patients with breast carcinoma].
    Mallmann P; Krebs D
    Zentralbl Gynakol; 1991; 113(12):689-96. PubMed ID: 1927118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
    Mallmann P; Krebs D
    Methods Find Exp Clin Pharmacol; 1990 Jun; 12(5):333-40. PubMed ID: 2232966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of adjuvant combined chemo/immunotherapy on immunological parameters and clinical course in patients with breast carcinoma].
    Mallmann P; Krebs D
    Zentralbl Gynakol; 1991; 113(12):697-706. PubMed ID: 1927119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy.
    Bozcuk H; Uslu G; Samur M; Yildiz M; Ozben T; Ozdoğan M; Artaç M; Altunbaş H; Akan I; Savaş B
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):58-65. PubMed ID: 15242694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations of leucocyte migration activating factor with interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha in drug allergy].
    Sano N; Uno K
    Arerugi; 1998 Nov; 47(11):1198-204. PubMed ID: 9893337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
    Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
    Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
    Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
    Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer.
    Gonullu G; Ersoy C; Ersoy A; Evrensel T; Basturk B; Kurt E; Oral B; Gokgoz S; Manavoglu O
    Cytokine; 2005 Aug; 31(4):264-9. PubMed ID: 15955709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients.
    El Agouza IM; Eissa SS; El Houseini MM; El-Nashar DE; Abd El Hameed OM
    Angiogenesis; 2011 Sep; 14(3):321-30. PubMed ID: 21553281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
    Giai M; Roagna R; Ponzone R; Biglia N; Sgro L; Perona M; Sismondi P
    Anticancer Res; 1996; 16(2):875-81. PubMed ID: 8687144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.